Scope Fluidics S.A.

Other research and experimental development on natural sciences and engineering

KRS: NIP: REGON:

Overview

Status
Active
Registry date
2017-03-27
Share capital
316,827.10 PLN
Activity description

Scope Fluidics is a biotechnology company that develops microfluidic technologies for medical diagnostics and healthcare. It owns Bacteromic, established to develop a system for assessing microorganisms’ drug susceptibility, and developed PCR|ONE for rapid diagnosis of bacterial and viral diseases through Curiosity Diagnostics, whose shares were acquired by Bio-Rad in 2022.

Registered address
ul. Ogrodowa 58, 00-876 Warszawa, Poland
Email
Phone
Social media
Electronic delivery address
AE:PL-73392-59550-CBSHE-24

Financials

Revenue history (in k)

Filing timeliness

Financial statements were filed on time, on average 41 days early. All were audited by a statutory auditor.

  • 202513/07/2026
  • 202427/06/2025
  • 202328/06/2024
  • 202203/04/2023
  • 202107/07/2022
  • 202007/07/2021
Filed on timeDelayFiling deadline

Data and insights are generated automatically from financial statements – they may contain errors and are neither a credit assessment nor business advice.

Stock quotes

PLN 142.00
-3.00 (-2.07%)
142.00144.00146.00148.00142.0010:0012:0014:0016:00
Open
PLN 145.20
High
PLN 148.00
Low
PLN 140.80
Volume
4.44K
Avg. vol.
2.02K
Market cap
PLN 449.89M
P/E ratio
–
EPS
-PLN 15.91
Shares outstanding
3.17M
52-week
PLN 137.00 – 148.00
Dividend yield
60.26%
Dividend
PLN 85.57
Ex dividend date
Mar 24, 2023
Exchange
GPW Main Market

Quarterly results

PeriodRevenueEBITNet profit
Q2 2026USD -0.04USD -1.46kUSD 26.95
Q1 2026USD 0.01USD -1.30kUSD 25.65
Q4 2025USD 0.01USD -7.25kUSD 25.25
Q3 2025USD 0.07USD -5.94kUSD -39.56

Results for Q3 2026:Nov 30, 2026

Statistics

How the company ranks by revenue within its industry, city, voivodeship and across Poland in 2025.

Top 14%
City · Warszawa14,494 / 56,729
Top 26%
Voivodeship · Mazowieckie20,321 / 76,892
Top 26%
Country · Poland80,362 / 297,069
Top 27%

Results vs industry

Revenue
This companyUSD 1.26mMedianUSD 73.13kAverageUSD 3.24m
Net profit
This companyUSD -11.64mMedianUSD 69.70AverageUSD 83.06k
Operating costs
This companyUSD 11.89mMedianUSD 75.83kAverageUSD 3.05m
Assets
This companyUSD 49.21mMedianUSD 120.25kAverageUSD 3.90m

Offer

  • Medical diagnostic systems
  • PCR|ONE system
  • BACTEROMIC system
  • Microfluidic research
  • Diagnostic device development
  • Clinical trials

Websites

The site is available in: Polish and English.

  • scopefluidics.comScope Fluidics – SCOPE FLUIDICS
    WordPress 3.7ElementorGoogle AnalyticsGoogle Tag ManagerYoast SEOWPMLLiteSpeed

Trademarks

The company holds 2 active trademarks registered with the Polish Patent Office. The first mark was filed in 2012.

MarkNumberClassesStatusProtected until
Scope Fluidics (word)Z.56173710, 35, 36, 41, 42, 45Protected Oct 19, 2033
SCOPE fluidics Z.4027365, 10, 42Protected Jul 10, 2032
MarkProtected until
Scope Fluidics (word)Oct 19, 2033
SCOPE fluidics Jul 10, 2032

Job offers

The company has its own careers page: scopefluidics.com/career-scope-fluidics.

Authorized Representatives

Piotr Garstecki age 51 – President of the Management Board
Marcin Izydorzak age 52 – Vice President of the Management Board
Szymon Michał Ruta age 51 – Vice President of the Management Board

Manner of representation

The company is represented by two members of the management board acting jointly, or one member of the management board together with a commercial proxy.

Supervisory board

Andrzej Chądzyński age 50 – Supervisory Board Member
Robert Bogusław Przytuła age 52 – Supervisory Board Member
Robert Piotr Hołyst age 63 – Supervisory Board Member
Joanna Rzempała age 49 – Supervisory Board Member
Karolina Radziszewska age 51 – Supervisory Board Member

Beneficial owners

Scope Fluidics is a public company listed on the Warsaw Stock Exchange, so it does not report beneficial owners to the CRBR (Art. 58 of the Polish AML Act). Its shareholders are disclosed in stock-exchange reports.

Subsidiaries

NameStake
Bacteromic sp. z o.o.
100%

Capital group

NameOwnership
71%

Bank accounts

Registered as a VAT taxpayer on 2011-01-31.

Debt

No entries in the National Debtors Register (KRZ).

Public aid

4 public aid cases recorded, with a total value of $22,557.

PurposeGross amount
Aid compensating for the negative economic consequences of COVID-19, granted in limited amounts
$4,184
Aid compensating for the negative economic consequences of COVID-19, granted in limited amounts
$4,472
Aid compensating for the negative economic consequences of COVID-19, granted in limited amounts
$3,644

Regulatory authorisations

AuthorityTypeStatus
BDO register entry Active

Competitors

Change history

DateEvent
2025-11-26Share capital increase
2023-01-26Address change
2022-11-15Share capital increase
2020-11-30Share capital increase
2020-04-07Share capital increase

FAQ

Last updated: 2026-07-16